Skip to main content
CTOS 2024 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon) (he/him/his)

Board Chair
Ethos Discovery

Dr. Chand Khanna is the founder and board chair of Ethos Discovery, a non-profit incubator of scientific innovation with a deep interest in solving complex medical problems and improving patient outcomes.

Dr. Chand Khanna graduated Western College of Veterinary Medicine, in Saskatoon and received specialty training in the fields of veterinary IM & Oncology, from Ontario Veterinary College, UGuelph, and UMN. Dr. Khanna received a Ph.D. in Pathobiology from UMN and then completed a post-doctoral fellowship with Dr. Lee Helman in the Pediatric Oncology Branch of NCI in Maryland.

Following his post-doctoral fellowship, Dr. Khanna continued his work at NCI as the Head of the Pediatric Oncology Branch’s Tumor and Metastasis Biology Section and Founding Director of the Center for Cancer Research, Comparative Oncology Program. In 2011, Dr. Khanna was granted full tenure and promoted to the position of Senior Investigator at NCI. His research interests & responsibilities focused on the problem of cancer metastasis & the development of new options to treat patients with metastasis. He has many publications in the area of cancer biology and therapy. He is the editor of a new textbook entitled, “Therapeutic Strategies in Veterinary Oncology.

Dr. Khanna held leadership roles in both veterinary and human oncology, including, President of ACVIM, Chair of the Children’s Oncology Group Bone Biology Subcommittee, Director of the SARC (Sarcoma Alliance for Research through Collaboration) Developmental Therapeutics Committee. Dr. Khanna is a founding member of the Canine Comparative Oncology and Genomics Consortium. Dr. Khanna is a two-time recipient of the NCI Distinguished Mentor Award and was the 2010 recipient of the NCI Award for Outstanding Research. Dr. Khanna has numerous board responsibilities in biopharma and the nonprofit cancer research space.

Dr. Khanna identifies as a clinician first and was an active clinician within his referral oncology practices, until 2021.

Poster(s):

Email Chand